130 related articles for article (PubMed ID: 16181992)
1. An introduction to molecular analysis and characterization of gliomas.
Ausman JI
Surg Neurol; 2005 Oct; 64(4):285. PubMed ID: 16181992
[No Abstract] [Full Text] [Related]
2. Neuropathological and molecular aspects of low-grade and high-grade gliomas.
Michotte A; Neyns B; Chaskis C; Sadones J; In 't Veld P
Acta Neurol Belg; 2004 Dec; 104(4):148-53. PubMed ID: 15742604
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetic markers as predictors of response to chemotherapy in gliomas.
Idbaih A; Omuro A; Ducray F; Hoang-Xuan K
Curr Opin Oncol; 2007 Nov; 19(6):606-11. PubMed ID: 17906460
[TBL] [Abstract][Full Text] [Related]
4. [Plasticity of malignant tumor cells].
Kofman AV
Tsitologiia; 2011; 53(10):832-3. PubMed ID: 22232941
[No Abstract] [Full Text] [Related]
5. Molecular angiogenic signaling in angiofibromas after embolization: implications for therapy.
Ngan BY; Forte V; Campisi P
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1170-6. PubMed ID: 19015446
[TBL] [Abstract][Full Text] [Related]
6. Proteomics-based analysis of a pair of glioma cell lines with different tumor forming characteristics.
Zhou L; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
Neurosci Lett; 2006 Jun; 401(1-2):59-64. PubMed ID: 16567038
[TBL] [Abstract][Full Text] [Related]
7. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
[TBL] [Abstract][Full Text] [Related]
8. EGFR activation results in enhanced cyclooxygenase-2 expression through p38 mitogen-activated protein kinase-dependent activation of the Sp1/Sp3 transcription factors in human gliomas.
Xu K; Shu HK
Cancer Res; 2007 Jul; 67(13):6121-9. PubMed ID: 17616668
[TBL] [Abstract][Full Text] [Related]
9. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.
Addo-Yobo SO; Straessle J; Anwar A; Donson AM; Kleinschmidt-Demasters BK; Foreman NK
J Neuropathol Exp Neurol; 2006 Aug; 65(8):769-75. PubMed ID: 16896310
[TBL] [Abstract][Full Text] [Related]
10. Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.
Hong X; Jiang F; Kalkanis SN; Zhang ZG; Zhang X; Zheng X; Mikkelsen T; Jiang H; Chopp M
J Exp Ther Oncol; 2007; 6(3):219-29. PubMed ID: 17552362
[TBL] [Abstract][Full Text] [Related]
11. Molecular markers of extracellular matrix remodeling in glioblastoma vessels: microarray study of laser-captured glioblastoma vessels.
Pen A; Moreno MJ; Martin J; Stanimirovic DB
Glia; 2007 Apr; 55(6):559-72. PubMed ID: 17266141
[TBL] [Abstract][Full Text] [Related]
12. Telomerase subunits expression variation between biopsy samples and cell lines derived from malignant glioma.
Shervington A; Patel R; Lu C; Cruickshanks N; Lea R; Roberts G; Dawson T; Shervington L
Brain Res; 2007 Feb; 1134(1):45-52. PubMed ID: 17196947
[TBL] [Abstract][Full Text] [Related]
13. Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1.
Zhang J; Zhao P; Fu Z; Chen X; Liu N; Lu A; Li R; Shi L; Pu P; Kang C; You Y
Oncol Rep; 2008 Dec; 20(6):1457-63. PubMed ID: 19020728
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
Al-Dissi AN; Haines DM; Singh B; Kidney BA
Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
[TBL] [Abstract][Full Text] [Related]
15. Correspondence re: B. H. Joshi et al., interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas. Cancer Res., 60: 1168-1172, 2000.
Debinski W
Cancer Res; 2001 Jul; 61(14):5660-2. PubMed ID: 11454721
[No Abstract] [Full Text] [Related]
16. Expression of CRM1 in human gliomas and its significance in p27 expression and clinical prognosis.
Shen A; Wang Y; Zhao Y; Zou L; Sun L; Cheng C
Neurosurgery; 2009 Jul; 65(1):153-9; discussion 159-60. PubMed ID: 19574837
[TBL] [Abstract][Full Text] [Related]
17. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
[TBL] [Abstract][Full Text] [Related]
18. Comments on plasmalemmal vesicle associated protein-1 as a novel marker implicated in brain tumor angiogenesis.
Sanders Strickland LA; Koeppen H
Clin Cancer Res; 2006 Apr; 12(8):2649; 2649-50. PubMed ID: 16638883
[No Abstract] [Full Text] [Related]
19. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of VEGF expression and related neo-angiogenesis in childhood high-grade gliomas: implications for anti-angiogenic anti-neoplastic therapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2006; 20(4):511-8. PubMed ID: 16900782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]